Latest News and Press Releases

Houston, Texas and Tuebingen, Germany, April 23, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the discovery and development of...

Longeveron issues letter to shareholders highlighting corporate strategy, recent progress and 2025 key priorities and goals.

The agreement would facilitate providing Tevogen Bio with in-house cell therapy production capabilitiesFormalized agreement aligns with previously announced topline forecasts WARREN, N.J., April ...

RMAT designation was granted based on promising clinical data from the ongoing Phase 1/2 trial of LYL314 in patients with relapsed and/or refractory large B-cell lymphoma.RMAT designation recognizes...

Dublin, April 14, 2025 (GLOBE NEWSWIRE) -- The "Cell & Gene Therapies in CNS Disorders" report has been added to ResearchAndMarkets.com's offering.Currently, there are nine cell and gene...

Dublin, April 09, 2025 (GLOBE NEWSWIRE) -- The "Current Research and Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market" report has been added to ResearchAndMarkets.com's...

KSQ Therapeutics Announces First Patient Dosed in Phase 1/2 Study for KSQ-004EX, a CRISPR/Cas9-Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapy

Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Cell Therapy Packaging Market Industry Trends and Global Forecasts to 2035, by Type of Therapy Packed, Package Engineering Design, Scale of Operation...

Dublin, April 04, 2025 (GLOBE NEWSWIRE) -- The "Cell Therapy Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Cell Therapy, Source of Cells, Scale of Operation, Type of...

Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline